ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,024Medicare Part D Prescriptions Filled, Including Refills

Rank: 574 out of 1456

$545K Total Retail Price of All Prescriptions

Rank: 391 out of 1456

380 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 387 355 1 1
LISINOPRIL 243 196 2 3
ATORVASTATIN CALCIUM 221 204 3 11
LEVOTHYROXINE SODIUM 207 144 4 4
CRESTOR 200 134 5 26
HYDROCHLOROTHIAZIDE 199 180 6 10
PRAVASTATIN SODIUM 143 111 7 9
CITALOPRAM HBR 134 113 8 22
SIMVASTATIN 133 114 9 2
OMEPRAZOLE 129 108 10 5
FUROSEMIDE 129 86 10 7
HYDROCODONE-ACETAMINOPHEN 128 88 S3 12 6
METFORMIN HCL 105 83 13 8
DONEPEZIL HCL 95 95 14 29
CARVEDILOL 95 51 14 20
METOPROLOL TARTRATE 89 77 16 12
NEXIUM 86 70 17 23
NAMENDA 85 82 18 38
ZOLPIDEM TARTRATE 84 75 19 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 53 20 24
POTASSIUM CHLORIDE 76 57 21 15
SERTRALINE HCL 75 66 22 25
METFORMIN HCL ER 74 74 23 54
MELOXICAM 68 53 24 30
ALLOPURINOL 67 60 25 31
METOPROLOL SUCCINATE 66 59 26 19
FENOFIBRATE 65 49 27 56
LIPITOR 65 63 27 76
WARFARIN SODIUM 64 60 29 21
DIOVAN 62 62 30 35
INSULIN SYRINGE 61 40 31 64
CIPROFLOXACIN HCL 55 48 32 58
FLUTICASONE PROPIONATE 53 28 33 28
LOSARTAN POTASSIUM 52 48 34 16
HUMALOG MIX 75-25 51 34 35 303
LYRICA 51 35 35 91
CLOPIDOGREL 50 41 37 32
ATENOLOL 50 42 37 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.